Description

Composition

• CJC-1295 (Without DAC): 5 mg
• Ipamorelin: 5 mg
• Appearance: Lyophilized powder in a sealed research vial

Research Focus (non-clinical)

• Comparative and combined pathway evaluation of GHRH analog + GHS agonist in in-vitro or ex-vivo models
• Assessment of assay development, including chromatographic separation of co-formulated peptides
• Stability characterization of a two-analyte lyophilized blend under laboratory storage conditions

Important Notice

• For research use only
• Not for human consumption
• Not intended to diagnose, treat, cure, or prevent any disease

Quality & Manufacturing

• Lot-specific COA
• Lyophilized for transit stability; batch traceable
• Tamper-evident seal; lot & test date on each vial
• No MOQ for online orders
• Bulk orders for physical locations start at 25-unit minimum